tions containing AT activity that eluted between pH 5.5 and 6.5 were pooled, and the pool was concentrated to approximately 5 ml in an Amicon (Amicon Corp.) concentration device using a UM-2 ultrafilter.
Molecular Sieve Chromatography.--A 3.5 X 200 cm Sephadex G-100 (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) column was equilibrated with acetic acid-sodium acetate buffer, pH 3.7, ionic strength 0.1. A mixture of the sample and 10% (vol/vol) of a saturated sucrose solution was layered between the top of the Sephadex column and the supernatant buffer. The flow rate was 12 ml/h, and 3-ml fractions were collected. Fractions containing AT activity were pooled and concentrated.
Chromatography on CM-Sephadex C50.--The concentrated pools containing AT activity from two, and at times three, different gel filtrations were chromatographed, a 2 X 30 cm CMSephadex C50 column equilibrated with 0.02 M sodium acetate buffer, pH 5.5, being used. The protein was eluted with a linear salt concentration gradient from a conductance of 2.0-38 mmho/cm. 500 ml each of 0.02 and 0.5 M ammonium formate were adjusted with distilled water to a conductance of 2 and 38 mmho/cm, respectively.
Gel Filtration on Sephadex G-25.--A sample of the active material from the CM-Sephadex chromatography was labeled with 125I (10) . The specific radioactivity was approximately 4,500 cpm/#g of protein. Gel filtration was carried out on a 2 )< 90 cm G-25 column equilibrated with acetic acid-sodium acetate buffer, pH 3.7, ionic strength 0.1. The flow rate was 4 ml/hr and 1-ml fractions were collected. The eluted protein emerged as a single peak after recycling.
Molecular Weight.--The molecular weight was estimated according to Andrews' method (11) , employing a 3.5 )< 200 cm Sephadex G-100 column equilibrated with acetic acid-sodium acetate buffer, pH 3.7, ionic strength 0.1. As reference substances, BSA, cytochrome c, and glucagon were used.
The polyacrylamide gel electrophoresis method of Hedrick and Smith (12) was also used for determinations of molecular weight. The gel concentration ranged from 5 to 12%. Betaalanine acetic acid buffer, pH 4.5, was employed. Reference substances were lysozyme (14,500), papain in its monomeric and dimeric form (21,000 and 42,000), and trypsin (23,800).
lmmunochemlcal and Electrophoretic Analyses.--The double diffusion in gel method was used for the detection of AI in NHS, in AI-depleted serum, and in the eluate from the anti-AI immune adsorbent. Monospecific rabbit antiserum to AI was used.
Immunoelectrophoresis was performed using 2% agarose in phosphate buffer, pH 6.0, ionic strength 0.05, with 0.01 M EDTA, and 2% agar in barbital buffer, pH 8.6, with 0.01 M EDTA. Disc electrophoresis was performed according to the method of Reisfeld et al. (13) , 6% resolving gel and fl-alanine acetic acid buffer, pH 4.5, being used. Analytical electrophoresis on cellulose acetate strips was carried out in a Beckman (Beckman Instruments, Inc., Fullerton, Calif.) mierozone electrophoresis apparatus, model P,-101, using a Beckman barbital buffer (pH 8.5), ionic strength 0.075, and 250 V for 20 rain at 20°C.
RESULTS

Depletion of AI in Human Serum by Immune
Adsorption.--Human serum was depleted of AI by immune adsorption. No AI was detectable in the treated serum by Ouchterlony test (Fig. 1) . The protein eluted from the immune adsorbent gave a precipitin line identical with the line obtained with fresh NHS, The AI-depleted serum was no longer able to inactivate isolated C3a and C5a AT activity. The eluted protein that was immunochemically identical with AI lacked enzymatic AI activity. The activity was not restored by addition of magnesium chloride or cobalt chloride.
FIG. 1. Absence of immunochemically detectable AI in immune-adsorbed NHS (Ads.).
Analysis was performed by Ouchterlony test using an anti-AI. The precipitating lines resulting from AI present in NHS (NHS) and the eluted protein from the solidified antibody (El.) fused completely.
A T Generation in Serum
Depleted of AI by Immune Adsorption.--As depicted in Fig. 2 , NHS by itself, after incubation at 37°C, or after activation with inulin, yeast, or immune complexes, was not able to generate smooth muscle contractile activity. However, after removal of AI, contraction of the guinea pig ileum was evoked by application of 50-100 #1 of serum that had been incubated for 60 rain at 37°C. The active material present in the serum was functionally identified as C3a since the muscle was unresponsive to 15 #g of isolated C3a. Further activation of the same serum with yeast caused full contraction of the C3a-desensitized guinea pig ileum. As we shall show, this material was identifiable with C5a AT.
Immunoehemical Demonstration of C3a in Human Serum.--AI-depleted
serum was incubated at 37°C for 60 rain and then subjected to immunoelectrophoresis. The pattern was developed with anti-C3a. C3a was readily detectable as a cathodally migrating protein (Fig. 3 ). An antiserum to C3 revealed that about 50% of the protein had undergone conversion. Neither C3a nor the anodally migrating conversion products can be seen in untreated fresh serum. It is of interest that the conversion of C3 and dissociation of active C3a occurred at neutral pH. Table I . Cysteine and the chelators were the most effective inhibitors examined. Some amino acids or amino acid analogues were also active, but only at relatively high concentrations. Compounds with the amino group in the alpha, beta, and omega position were not inhibitory. Of all AI inhibitors, only EACA allowed generation of AT. All other inhibitors also inhibited AT formation. Inhibition of AI by EACA and cadmium sulfate is
Inhibition of A I in Whole Human
Ads. Ads.
Tracing produced by contraction of guinea pig ileum, showing biological activity in AI-depleted serum (NHS Ads.) after incubation at 37°C for 60 min without any additions. NHS, incubated NHS at 37°C for 60 min with immune complexes, inulin, or yeast. Repeated applications of NHS Ads. produced tachyphylaxis and cross-tachyphylaxis for isolated human C3a. However, the muscle was still fully reactive to histamine (H) and to the biological activity generated after incubation of NHS Ads. at 37°C for 60 min with yeast, which could be identified with CSa activity. similar to that of carboxypeptidase N or kinase I, described by Yang and ErdSs (14) . These substances do not inhibit kininase II.
Modes of A T Generation in Whole Human Serum.--Biologically active C3a
and CSa may be obtained by treating whole h u m a n serum with a variety of substances after inhibition of AI by EACA. Thus, antigen-antibody complexes, 
Examination of Various Compounds for Inhibitory Effect on Anaphylatoxin Inactivator
Compound Concentration* AI Inhibition (#1 treated serum/10/~g C3a) 5 10 25 Isolation of C5a A T from Human Serum.--Fresh NHS treated overnight with 1 M EACA was used as starting material. After activation with boiled yeast, the yeast was removed and the pH was adjusted to 3.7. This material was chromatographed on CM-cellulose in ammonium formate, and the AT activity was eluted between pH 5.5 and 6.5 (Fig. 4) . After concentration, this material was passed over a column of Sephadex G-100. The elution profile and the position of AT activity in relation to known markers is illustrated in Fig.  5 . Fractions containing AT activity from two, and at times three, different gel filtrations were pooled and chromatographed using a CM-Sephadex C50 column (Fig. 6 ). The peak of activity was eluted at a conductance of 32 mmho/ cm and at a pH of 6.2. After concentration, the active material was passed over a Sephadex G-25 column and recycled to demonstrate molecular homogeneity of the isolated protein (Fig. 7) . The purification achieved at each step of the isolation procedure is indicated in Table II . The average yield was 250 #g/liter of serum. Usually 17% of the original activity present in the activated serum was recovered. As will be described elsewhere, active C3a could also be isolated from whole human serum containing EACA. (Fig. 10 ). By comparison with the known electrophoretic mobilities of albumin, transferrin, gamma globulin, and human C3a, the mobilities of human and pig ATs were estimated to be, respectively, --1.7 and --1.2 X 10 .5 cm 2 V -1 s -t (Fig. 11) . The diffusion coefficient was estimated by molecular sieve chromatography on Sephadex G-100 to be 12.1 X 10. 7 cm2/s and the molecular weight to be 17,500 daltons (Fig. 12) . By the gel electrophoresis method a molecular weight of 16,500 was obtained (Fig. 13) .
The minimal effective concentration when CSa AT was tested in the guinea pig ileum assay was 7.5 X 10 -~° M. Introduced into the human skin by intradermal injection, the minimal effective dose required to produce a wheal and erythema reaction was 1 X 10 -t5 tool. As shown in Fig. 14 , isolated AT obtained by contact activation of whole human serum produced completed desensitization of the guinea pig ileum to C5a AT obtained by trypsin treatment of isolated C5. As indicated in the same figure, this AT was also inactivated by isolated AI. Smooth muscle-contracting activity was also eluted from polyacrylamide gels after electrophoresis of CSa, and the activity distribution coincided with the protein distribution.
DISCUSSION
Our present investigations demonstrated unequivocally the potential biological significance of both human ATs and of their control mechanism, the AI. We showed that removal or inactivation of AI allowed generation of both Migration Distance [mm] Fio. 11. Electrophoretic mobilities of human and porcine CSa ATs in relation to those of reference substances. The electrophoretie mobility was --1.7 X 10 -5 cm 2 V -1 s -1 for the human and --1.2 X 10 -5 cm 2 V -I s -1 for the pig AT, respectively.
ATs, C3a and CSa, in whole h u m a n serum. Furthermore, both fragments could be d e m o n s t r a t e d by immunochemical techniques. Thus, the well-known failure of h u m a n serum to serve as a source for A T s could be explained in terms of the function of the AI, the previously described carboxypeptidase B ( C P B ) -like enzyme of normal serum (5) . Accordingly, h u m a n serum is not significantly different with respect to A T production from the sera of other species, such as pig, guinea pig, or rat. 13 . Determination of molecular weight of human C5a by the gel electrophoresis method of Hedrick and Smith. The slopes were calculated from log relative mobility vs. gel concentration plots. Solid triangle, lysozyme (mol wt = 14,500). Solid circles, monomeric and dimeric form of papain (tool wt = 21,000 and 42,000, respectively). Open circle, trypsin (tool wt = 23,800). The molecular weight of C5a was found to be 16,500.
The difference between human and, for instance, porcine serum lies in the resistance of porcine CSa to inactivation by autologous AI. Further, a C3a analogue had never been demonstrated in whole serum of any species. As will be shown elsewheref C3a AT may be produced in whole porcine serum as it Fla. 14. Biologic activity of C5a isolated from yeast-activated human serum. Tracing produced by guinea pig ileum contraction upon applications of 1/~g of CSa. Repeated application produced desensitization for CSa obtained by trypsin treatment of isolated human C5. Tracing on the right shows inactivation of human C5a by AI (AT + AI). Mter treatment of CSa with AI, no contraction could be elicited, whereas identical amounts of untreated C5a produced a full contraction (AT). H indicates the effect of histamine.
was shown in these experiments to arise in whole human serum. However, as in human serum, it is rapidly inactivated by the porcine AI. The differential susceptibility of porcine C3a and C5a to AI action results in suppression of C3a activity and accumulation of C5a activity. In contrast, both activities are suppressed in whole human serum. Formation and fate of human and porcine ATs are schematically represented in Fig. 15 . The differential effect of AI on the ATs of experimental animals fully explains the fact that C3a escaped detection by the earlier students of AT.
Action of AI on C3a was shown to result in cleavage of the C-terminal arginine (5) . Similarly, preliminary investigations of human CSa indicate that this peptide, too, has a basic residue in C-terminal position. Inactivation appears to be caused by removal of the C-terminal residue in both instances. Since AI also inactivates porcine C3a, its C terminus is most probably also occupied by a basic amino acid. The demonstration of a neutral residue, leucine, in C-terminal position for porcine C5a (15) is consistent with the resistance of the peptide to inactivation by AI. However, it raises an important question as to the identity and bond specificity of the CSa-liberating enzyme in porcine serum. Human C3a appears to be liberated by cleavage of a peptide bond involving the carboxyl group of arginine (16) . The same appears to apply to human C5a. This is consistent with the tryptic nature of the C3-and C5-activating enzymes C4,2 and C4,2,3. The C3 activator of the alternate mechanism of complement activation also is trypsin-like (17) , and this assumption may be made for the enzyme liberating porcine C3a. However, if porcine C5a is dissociated from the N-terminal portion of its precursor by cleavage of a leucyl bond, the bond specificity of the responsible enzyme would be different from that of its human counterpart. Such dissimilarity in enzyme specificity within the same biological system occurring in two mammalian species is improbable. The identity of the C-terminal residue of porcine CSa therefore requires reexamination.
Aging of NHS has been shown to result in slow conversion of C3 (18, 19) . Our results indicated that after removal or inactivation of AI, mere incubation of NHS at 37°C resulted in generation of biologically and immunochemically detectable C3a. Addition of EACA accelerated the normally slow conversion to such an extent that no detectable native C3 was seen by immunoelectrophoresis after 4 h of incubation (Fig. 3) . Whether EACA enhances a serum enzyme directly or indirectly involved in C3 conversion or whether it interferes with a serum enzyme inhibitor has not been determined.
Previously, human C5a was obtained by enzymatic cleavage of C5 with trypsin or the C4,2,3 enzyme (4). Our results indicate that C5a, as is the case for hog and rat ATs, can be generated by activation of whole serum with inulin or fresh or boiled bakers' yeast. These substances are known to trigger the alternate pathway. Generation of ATs under these conditions was always accompanied by conversion of the C3 proactivator (C3PA) to its enzymatically active form (20) . Prevention of C3PA conversion by the use of high doses of heparin resulted in prevention of AT generation. Thus, AT formation by the methods used proceeded through the alternate mechanism of complement activation.
In the course of this work it was possible to demonstrate human C5a AT for the first time directly as a protein entity, through electrophoresis on acid polyacrylamide gels or cellulose acetate strips. The isolated peptide has a molecular weight of 16,500, which is more than twice that of C3a. It is not as basic as C3a; but when tested by intradermal injection in humans for causation of wheal and erythema, C5a appears almost 1,000 times more active than C3a on a molar basis (6) .
Immunochemical and structural studies are under way to define the characteristics of isolated ATs from different species. For comparison, some of the properties of human C3a and C5a are listed in Table III . With the methods at hand for isolating both peptides in active form directly from whole serum, it has now become feasible to undertake comparative structural studies and to determine the chemical basis of the AT biologic activities. Sephadex gel filtration (X 10 -7 cm 2 s-l). § Calculated nomographically. ][ Guinea pig ileum contraction. ¶ Wheal and erythema in human skin. SUMMARY TWO biologically and chemically distinct anaphylatoxins (ATs) could be generated in whole human serum after removal of the AT inactivator (AI) by immune-absorption or after inhibition of AI with 1 M epsilon-aminocaproic acid (EACA). Both human ATs could be generated by treatment of serum with antigen-antibody complexes, which activate the classical complement pathway, and with inulin or yeast, both of which trigger the alternate pathway. The ATs were isolated from serum in active form and characterized as C3a and C5a.
Although human C3a had been characterized previously, C5a had not. The molecular weight of human CSa AT was 17,500; its electrophoretic mobility at pH 8.5 was -1.7 X 10 -~ cm 2 V -1 s -1. The minimal effective concentration in vitro was 7.5 X 10 -1° M. The minimal effective doses of human C5a in producing a wheal and erythema in the human skin was 1 X 10 -15 mol. The results strongly suggest a biological function for both ATs and indicate that the expression of their activity is controlled by the AI of normal blood plasma.
